 The stock price of Repligen NASDAQ: RGEN, a U.S.-based life sciences company involved in production of materials used in the manufacture of biological drugs, has seen a 12 drop over the last twenty-one trading days. The company last month announced the acquisition of Avitide - a privately held. 